STOCK TITAN
  1. Home
  2. Sec-filings
  3. MAZE
  4. [144] Maze Therapeutics, Inc. SEC Filing

Maze officer may sell stock for tax withholding

An officer of Maze Therapeutics filed a Rule 144 notice reflecting issuer-mandated sales tied to RSU vesting and recent 7,500-share transactions.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Maze Therapeutics, Inc. (MAZE) has a notice of proposed sale of common stock filed on behalf of officer Atul Dandekar under Rule 144. The stock relates to restricted stock units that vested as compensation, and the company mandated a sale of shares to cover tax withholding obligations tied to that vesting.

The notice also lists recent sales by Dandekar over the prior three months, each for 7,500 shares of Maze common stock, with aggregate proceeds a little above $200,000 per transaction.

Positive

  • None.

Negative

  • None.
Shares sold June 29, 2026 7,500 shares Securities sold during the past 3 months by the officer
Proceeds June 29, 2026 $210,150.00 Aggregate proceeds for 7,500 shares sold June 29, 2026
Shares sold July 29, 2026 7,500 shares Securities sold during the past 3 months by the officer
Proceeds July 29, 2026 $205,031.44 Aggregate proceeds for 7,500 shares sold July 29, 2026
Shares sold August 28, 2026 7,500 shares Securities sold during the past 3 months by the officer
Proceeds August 28, 2026 $206,823.75 Aggregate proceeds for 7,500 shares sold August 28, 2026
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock units financial
"vesting and settlement of restricted stock units granted"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"includes an amount necessary to satisfy tax withholding obligations"
equity incentive award financial
"units granted pursuant to an equity incentive award"
Equity incentive award is a grant of company ownership or the right to buy ownership—such as stock, restricted shares, or options—given to employees, executives, or directors as part of their pay. Investors care because these awards align workers’ interests with shareholders (like giving someone slices of a pie so they try to make the pie bigger), but they also dilute existing ownership and increase reported compensation costs, which can affect share value and earnings per share.

FAQ

What does the Form 144 filing mean for MAZE?
It reports that officer Atul Dandekar may sell Maze Therapeutics common stock under Rule 144. The shares relate to restricted stock units that vested as compensation, and the issuer mandated a sale sufficient to satisfy related tax withholding obligations.

Who is selling Maze Therapeutics (MAZE) stock in this Form 144?
The notice is filed for Atul Dandekar, identified as an officer of Maze Therapeutics, Inc. It covers Maze common stock held for his account, including shares from restricted stock unit vesting under an equity incentive award.

How many MAZE shares did the officer sell recently?
Over the past three months, the officer reported three sales of 7,500 shares each of Maze common stock, dated June 29, 2026, July 29, 2026, and August 28, 2026, as part of the historical sales section in the notice.

What dollar amounts were involved in the recent MAZE stock sales?
The three reported sales produced aggregate proceeds of $210,150.00 on June 29, 2026, $205,031.44 on July 29, 2026, and $206,823.75 on August 28, 2026, for 7,500 shares in each transaction.

Why were some MAZE shares sold according to this notice?
The remarks state that the reported sale was mandated by the issuer and includes shares sold to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units granted under an equity incentive award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR